Enrico Martin

103 Oncological treatment considerations 45. Hirbe AC, Cosper PF, Dahiya S, et al. Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors. Sarcoma . 2017;2017:3761292. doi:10.1155/2017/3761292 46. Martin E, Lamba N, Flucke UE, et al. Non-cytotoxic systemic treatment in malignant peripheral nerve sheath tumors (MPNST): A systematic review from bench to bedside. Crit Rev Oncol Hematol . 2019;138:223-232. doi:10.1016/j. critrevonc.2019.04.007 47. Pasquali S, Colombo C, Pizzamiglio S, et al. High-risk soft tissue sarcomas treated with perioperative chemotherapy: Improving prognostic classification in a randomised clinical trial. Eur J Cancer . 2018;93:28-36. doi:10.1016/j.ejca.2018.01.071 48. van Praag VM, Rueten-Budde AJ, Jeys LM, et al. A prediction model for treatment decisions in high-grade extremity soft- tissue sarcomas: Personalised sarcoma care (PERSARC). Eur J Cancer . 2017;83:313- 323. doi:10.1016/j.ejca.2017.06.032 5